Growth Metrics

Intelligent Bio Solutions (INBS) Total Liabilities (2019 - 2024)

Intelligent Bio Solutions has reported Total Liabilities over the past 6 years, most recently at $6.0 million for Q1 2024.

  • Quarterly results put Total Liabilities at $6.0 million for Q1 2024, up 27.4% from a year ago — trailing twelve months through Mar 2024 was $6.0 million (up 27.4% YoY), and the annual figure for FY2023 was $6.7 million, up 14.83%.
  • Total Liabilities for Q1 2024 was $6.0 million at Intelligent Bio Solutions, up from $5.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for INBS hit a ceiling of $7.8 million in Q4 2022 and a floor of $1.2 million in Q4 2020.
  • Median Total Liabilities over the past 5 years was $5.7 million (2023), compared with a mean of $5.4 million.
  • Biggest five-year swings in Total Liabilities: tumbled 79.84% in 2020 and later surged 338.3% in 2021.
  • Intelligent Bio Solutions' Total Liabilities stood at $1.2 million in 2020, then surged by 338.3% to $5.2 million in 2021, then soared by 49.97% to $7.8 million in 2022, then fell by 27.13% to $5.7 million in 2023, then increased by 6.49% to $6.0 million in 2024.
  • The last three reported values for Total Liabilities were $6.0 million (Q1 2024), $5.7 million (Q4 2023), and $7.5 million (Q3 2023) per Business Quant data.